半边旗和千金子化学成分研究
|
摘要
中国有着非常丰富的中草药资源,对中国中草药的化学成分进行系统的研究,以期发现具有重要活性的先导化合物是创新药物发现的重要途径之一,同时可以为中草药的进一步开发和利用提供科学依据。本论文利用正相硅胶、反相材料(RP-18,MCI)以及凝胶(Toyopearl HW-40C)对两种药用植物半边旗(Pteris semipinnata L.)和千金子(Euphorbia lathyris L.)的化学成份进行了系统详细的研究,共分离得到20个化合物。通过现代分析手段,如紫外光谱(UV)、红外光谱(IR)、质谱(MS)及核磁共振技术(NMR),尤其是二维核磁(~1H-~1HCOSY,HSQC,HMBC,NOESY)技术对化合物结构进行了鉴定,确定了19个化合物的结构,其中5个为新化合物。
从半边旗中分离得到13个化合物,鉴定了其中的12个,其中5个新化合物,包括1个新1H-茚-1-酮型倍半萜,1个新对映贝壳杉烷型二萜,1个新1H-茚-1-酮型倍半萜苷,1个新半日花烷型二萜苷和1个新1H-茚-1-醇型倍半萜。
从千金子中分离坚定了7个化合物,包括单油酸甘油酯,巨大戟二萜醇,七叶内酯及4个续随子型二萜,其中单油酸甘油酯首次从千金子中分离出。
China has abundant Chinese traditional and herbal drugs resources. Investigation on the chemical and biological constituents of Chinese traditional and herbal drugs is important for the discovery of new drug leads and the endowment of scientific background for Chinese traditional and herbal drugs.In this paper,the chemical and biological constituents of two plant species,Pteris semipinnata L.and Euphorbia lathyris L.were carried out.Twenty compounds were totally isolated,and the structures of nineteen compounds were established by utilization spectral methods such as IR,UV,MS,NMR,especially 2D NMR techniques(~1H-~1H COSY, HSQC,HMBC,NOESY).Among them,five are structurally new compounds.
Thirteen compounds were isolated from Pteris semipinnata L.,the structures of twelve compounds were established,in which there were five new compounds,including one new 1-H-indan-1-one-type sesquiterpenoid, one new ent-kaurane-type diterpenoid,one new 1-H-indan-1-one-type sesquiterpene glucoside,one new labdane-type diterpene glucoside and one new 1-H-indan-1-ol-type sesquiterpenoid.
Seven compounds were isolated from Euphorbia lathyris L.,including glycerol monooleate,ingenol,aesculetin,and four lathyrane-type diterpenoids.Among them,glycerol monooleate is obtained from Euphorbia lathyris L.for the first time.
从半边旗中分离得到13个化合物,鉴定了其中的12个,其中5个新化合物,包括1个新1H-茚-1-酮型倍半萜,1个新对映贝壳杉烷型二萜,1个新1H-茚-1-酮型倍半萜苷,1个新半日花烷型二萜苷和1个新1H-茚-1-醇型倍半萜。
从千金子中分离坚定了7个化合物,包括单油酸甘油酯,巨大戟二萜醇,七叶内酯及4个续随子型二萜,其中单油酸甘油酯首次从千金子中分离出。
China has abundant Chinese traditional and herbal drugs resources. Investigation on the chemical and biological constituents of Chinese traditional and herbal drugs is important for the discovery of new drug leads and the endowment of scientific background for Chinese traditional and herbal drugs.In this paper,the chemical and biological constituents of two plant species,Pteris semipinnata L.and Euphorbia lathyris L.were carried out.Twenty compounds were totally isolated,and the structures of nineteen compounds were established by utilization spectral methods such as IR,UV,MS,NMR,especially 2D NMR techniques(~1H-~1H COSY, HSQC,HMBC,NOESY).Among them,five are structurally new compounds.
Thirteen compounds were isolated from Pteris semipinnata L.,the structures of twelve compounds were established,in which there were five new compounds,including one new 1-H-indan-1-one-type sesquiterpenoid, one new ent-kaurane-type diterpenoid,one new 1-H-indan-1-one-type sesquiterpene glucoside,one new labdane-type diterpene glucoside and one new 1-H-indan-1-ol-type sesquiterpenoid.
Seven compounds were isolated from Euphorbia lathyris L.,including glycerol monooleate,ingenol,aesculetin,and four lathyrane-type diterpenoids.Among them,glycerol monooleate is obtained from Euphorbia lathyris L.for the first time.
引文
[1]龚先玲,陈志红,梁念慈.凤尾蕨属植物化学成分及药理活性研究进展[J].中国中药杂志,2007,32(14):1382-1387.
[2]Fuji K,Xu H J,Tatsumi H,et al.Design and synthesis of antitumor compouds based on the cytotoxic diterpenoids from the genus Rabdosia[J].Chem Pharm,1991,39(3):685-689.
[3]Murakami T,Tanaka N,Hata M,et al.Chemical and chemotaxonomic studies on the genus Pteris and related genera(Pteridaceae).Ⅺ.Chemical studies on the constituents of Pteris dispar Kunze[J].Chem Pharm,1976,24(3):549-551.
[4]Aoyama K,Tanaka N,Suzuki N,et al.Chemical and chemotaxonomic studies on the genus Pteris and related genera(Pteridaceae).ⅩⅥ.New pterosin derivatives from Pteris wallichiana Agardh.and P.semipinnata L[J].Chem Pharm,1977,25(9):2461-2564.
[5]Murakami T;Iida H,Tanaka N,et al.Chemical and chemotaxonomic studies of ferns.ⅩⅩⅩⅢ.Chemical studies on the constituents of Pteris longipes Don[J].Chem Pharm,1981,29(3):657-662.
[6]Tanaka N,Murakami T,Saiki Y,et al.Chemical and chemotaxonomic studies on the of ferns.ⅩⅩⅩⅦ.Chemical studies on the constituents of costa rican ferns(2)[J].Chem Pharm,1981,29(12):3455-3463.
[7]李金华,梁念慈,莫立儿,等.半边旗5种成分体外细胞毒活性比较及构效关系分析[J].药学学报,1998,33(9):641-644.
[8]Tanaka N;Murakami T;Saiki Y,et al.Chemical and chemotaxonomic studies of ferns.ⅩⅩⅩⅣ.Chemical studies on the constituents of Pteris purpureorachis Copel[J].Chem Pharm,1981,29(3):663-666.
[9]Murakami T;Tanaka N,Komazawa Y;et al.Chemical and chemotaxonomic studies of fronds.XLI.Additional compounds from Pteris purpureorachis Copel[J].Chem Pharm,1983,31(5):1502-1504.
[10]Salatino M L F,Prado J.Flavonoid glycosides of Pteridaceae from Brazil[J].Bioch Syst,1998,26:761-769.
[11]Imperato F.A new flavone glycoside from the fern Pteris cretica[J].Cell Mol L,1994(11-12):1115-1116.
[12]Imperato F,Nazzaro R.Luteolin 7-O-sophoroside from the fern Pteris cretica[J].Phytochem,1996,41(1):337-338.
[13]秦波,朱大元.凤尾蕨科植物中倍半萜类成分的研究进展(Ⅰ)[J].化学研究,2004,15(2):72-76.
[14]Chen Y H,Chang F R,Lu M C,et al.New benzyl glucosides and cytotoxic pterosin sesquiterpenes from Pteris ensiformis Burm[J].Molecules,2008,13(2):255-266.
[15]Zhang Q,Xuan L J.Pterisemipol,a novel sesquiterpenoid from Pteris semipinnata L[J].Chin Chem L,2007,18(11):1386-1388.
[16]王萍兰,刘志杰,李顺举,等.几种蕨类植物内生真菌抑制病原菌的筛选[J].九江医学,2007,22(03):51-53.
[17]吕应年,蒋桂香,吴科锋,等.半边旗中黄酮成分的分离鉴定与抗氧化活性研究[J].化学世界,2007,48(4):205-208.
[18]江苏新医学院.中药大辞典[M](第二版).上海:上海科学技术出版社,1986:782-783
[19]陈焕镛.《海南植物志》[M]第一卷.北京:科学出版社,1964:73.
[20]张朝芳,章绍尧.《浙江植物志》[M].浙江科学技术出版社,1993:82-83.
[21]朱慧明,吴铁,崔燎,等.半边旗多糖对肺腺癌SPCA-1细胞的诱导凋亡作用[J].中国新药杂志,2003,2(12):1-3.
[22]朱慧明,吴铁,崔燎,等.半边旗多糖对人肺腺癌细胞株SPCA-1凋亡和端粒酶的影响[J].中国新药杂志,2003,2(11):6-8.
[23]龚先玲,陈志红,典灵辉,等.半边旗挥发油化学成分气相色谱-质谱计算机联用技术分析[J].时珍国医国药,2005,16(08):697-698.
[24]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞的DNA、RNA及蛋白质生物合成的抑制作用[J].广东医学院学报,2002,20(04):247-248.
[25]何承伟,梁念慈,莫丽儿,等.半边旗提取物6F抑制HL-60细胞蛋白激酶C活性(英文)[J].中国药理学与毒理学杂志,2003,17(02):81-86.
[26]何承伟,梁念慈,莫丽儿,等.半边旗提取物6F对HL-60细胞还原型谷胱甘肽(GSH)水平的影响[J].广东医学院学报,2002,20(05):333-334.
[27]李金华,梁念慈,莫丽儿,等.半边旗有效化合物对肺癌细胞DNA拓扑异构酶、 TPK及c-myc基因的影响[J].癌症,2000,19(8):763-767.
[28]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞c-Myc、Bcl-2及PCNA表达的抑制作用[J].广东医学院学报,2002,20(03):165-166.
[29]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞周期的影响及体外增效作用[J].癌症,1998,17(3):191-193.
[30]林意玲,吴平,廖海兰,等.半边旗二萜类化合物5F诱导人冀状胬肉成纤维细胞凋亡及对caspase-3表达的研究[J].中国药学杂志,2006,41(13):993-997.
[31]肖佐环,吴铁,吴志华,等.半边旗5F对系统性硬皮病患者成纤维细胞增殖和胶原合成的影响[J].中华皮肤科杂志,2003,36(01):31-34.
[32]何太平,莫丽儿,梁念慈.半边旗提取物5F对高转移卵巢癌细胞HO-8910PM侵袭转移的影响[J].中国药理学通报,2005,(05):540-544.
[33]何太平,莫丽儿,梁念慈.半边旗提取物5F对人高转移卵巢癌细胞HO-8910PM ETS-1mRNA和VEGF蛋白表达的影响[J].中药材,2005,28(4):307-309.
[34]何太平,莫丽儿,梁念慈.半边旗提取物5F对HO-8910PM细胞中NF-κB和FAK蛋白表达的影响[J].肿瘤防治杂志,2005,12(08):565-568.
[35]王京滨,梁念慈,莫丽儿.半边旗中二萜类化合物5F对K562细胞几种癌基因表达的影响[J].中国药理学通报,2002,8(04):418-421.
[36]刘义,吴育廉,邓亦峰,等.半边旗提取物5F对猪脑微管蛋白聚合的影响[J].中国药理学通报,2005,21(4):447-449.
[37]戴滨,崔燎,吴铁,等.半边旗提取物5F对SPCA-1细胞周期及DNA、RNA合成的影响[J].中国临床药理学与治疗学,2006,11(04):402-405.
[38]杨寿,吴平,何惠娟,等.半边旗二萜类化合物5F体外抗支气管哮喘小鼠气道纤维化的作用[J].中国医院药学杂志,2006,26(07):786-788.
[39]刘文,覃燕梅,梁念慈.半边旗中二萜类化合物5F对凝血酶诱导兔血小板聚集的影响[J].广东医学院学报,2000,18(01):9-10.
[40]何振辉,何太平,莫丽尔,等.白藜芦醇与半边旗二萜类化合物5F对活体血管生成的影响[J].实用医技杂志,2006,13(1):1-3.
[41]刘义,张薇,徐珠锦,等.半边旗提取物5F体外抑菌实验[J].牡丹江医学院学报, 2008,29(4):46-47.
[42]Tanaka N,Satake T,Takahashi A,et al.Chemical and chemotaxonomical studies of ferns.ⅩⅩⅪⅩ.chemical studies on the constituents of Pteris bella Tagawa and Pteridium aquilinum susp.wightianum(wall) shich[J].Chem Pharm,1982,30(10):3640-3646.
[43]Kuroyanagi M,Fukuoka M,Yoshihira K,et al.Circular dichroism and conformations of pterosins,1-indanone derivatives from braken[J].Chem Pharm,1979,27(3):731-741.
[44]Murakarni T,Maehashi H,Tanaka N,et al.Chemical and chemotaxonomical studies on filices.LV.Studies on the constituents of several species of Pteris[J].Yakugaku Zasshi,1985,105(7):640-648.
[45]Tori K,Seo S,Yoshimura Y,et al.Carbon-13 NMR spectra of saikosaponins A,C,D and F isolated from bupleurum falcatum L[J].Tetrahedr L,1976,17(46):4167-4170.
[46]Herz W,Sharma R P.New hydroxylated ent-kauranoic acids from Eupatorium album[J].J Org Chem,1976,41(6):1021-1026.
[47]Yamasaki K,Kohda H,Kobayyashi T,et al.Application of ~(13)C nuclear magnetic resonance spectroscopy to chemistry of glycosides:Structures of paniculosides-Ⅰ,-Ⅱ,-Ⅲ,-Ⅳ and Ⅴ diterpene glucosides of Stevia paniculata Lag[J].Chem Pharm,1977,25(11):2895-2899.
[48]张雪梅,李磊,张刚磊,等.3,4-二羟基苯甲醛合成工艺的改进[J].徐州师范大学学报(自然科学版),2006,24(3):52-54.
[49]邹国安.连翘和毛喉鞘蕊花活性成分及其质量分析研究[D].武汉:湖北中医学院,2006.
[50]Rahman M M A,Dewick P M,Jackson D E,et al.Lignans of Forsythia intermedia[J].Phytochem,1990,29(6):1971-1980.
[1]江苏新医学院编.中药大辞典[M](第二版).上海:上海科学技术出版,1986:216-217.
[2]Adolf W,Hecker E.On the active principles of the spurge familyⅢ.~* Skin irritant and cocarcinogenic factors from the caper spurge[J].Z Krebsforsch,1975,84(3):325-344.
[3]Appendino G,Porta C D,Conseil G,et al.A new P-glycoprotein inhibitor from the caper spurge(Euphorbia lathyris)[J].J Nat Prod.2003,66(1):140-142.
[4]徐珊,徐昌芬.肿瘤多药耐药性发生机制及中药逆转作用的研究进展[J].中国肿瘤生物治疗杂志,2006,13(6):404-411.
[5]危文亮,金梦阳,马冲,等.续随子油脂肪酸组成分析[J].中国油脂,2007,32(5):70-71.
[6]李昌珠,蒋丽娟,程树棋.生物柴油-绿色能源[M].北京:化学工业出版社,2004.
[7]Itolawa H,Ichihara Y,Yahagi M,et al.Lathyrane diterpenes from Euphorbia lathyris[J].Phytochem,1990,29(6):2025-2026.
[8]Liao S G,Zhan Z J,Yang S P,et al.Lathyranoic acid A:First secolathyrane diterpenoid in nature from Euphorbia lathyris[J].Org Lett,2005,7(7):1379-1382.
[9]Gao S,Liu H Y,Wang Y H,et al.Lathyranone A:A diterpenoid possessing an unprecedented skeleton from Euphorbia lathyris[J].Org Lett,2007,9(17):3453-3455.
[10]孔彩霞.千金子甲醇提取物抗肿瘤作用的实验研究及其有效成分理化性质的初步探讨[D].武汉:华中科技大学,2002.
[11]Itokawa H,Ichihara Y,Watanabe K,et al.An anti-tumor principle from Euphorbia lathyris[J].Planta Med.1989,55(3):271-272.
[12]黄晓桃,黄光英,薛存宽,等.千金子甲醇提取物抗肿瘤作用的实验研究[J].肿瘤防治研究,2004,31(9):556-557.
[13]李群,王琦,黄春凌,等.千金子炮制品中脂肪油成分的研究[J].中成药,1994,16(4):24-25.
[14]Masamoto Y,Ando H,Murata Y,et al.Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L[J].Bios Biot B,2003,7(3):631-634.
[15]Takara K,Sakaeda T,Okumura K.An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy[J].Curr Pharm Des,2006,12(3):273-286.
[16]Beck W T.The cell biology of multiple drug resistance[J].Bioch Pharma,1987,36(18):2879-2887.
[17]包鸿廷,韩曙光.一种治疗白血病的中药.中国:93103708.5[P].1994-10-5.
[18]邹义达.一种治疗膀胱癌的中药.中国:01131500.8[P].2002-4-17.
[19]王娟,陈金海山.一种治疗银屑病的中药组合物.中国:200410042859.5[P].2005-12-7.
[20]Appendino G,Porta C D,Conseil G,et al.An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris[J].J Nat Prod,1999,62(1):76-79.
[21]National Institute of Advanced Industrial Science and Technology(AIST),Japan.Spectral Database for Organic Compounds SDBS[DB/OL].[2008-01-20]http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/direct_frame_top.cgi.
[22]杨雁芳,阎玉凝.中药枸骨叶的化学成分研究[J].中国中医药信息杂志,2002,9(4):33-34.
[23]Kupchan S M;Uchida I;Branfman A R;et al.Antileukemic principles isolated from Euphorbiaceae plants[J].Science,1976,191(4227):571-572.
[24]Fujiwara M;Ijichin K;Tokuhisa,K.;et al.Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate[J].Antim Ag Ch,1996,40(1):271-273.
[2]Fuji K,Xu H J,Tatsumi H,et al.Design and synthesis of antitumor compouds based on the cytotoxic diterpenoids from the genus Rabdosia[J].Chem Pharm,1991,39(3):685-689.
[3]Murakami T,Tanaka N,Hata M,et al.Chemical and chemotaxonomic studies on the genus Pteris and related genera(Pteridaceae).Ⅺ.Chemical studies on the constituents of Pteris dispar Kunze[J].Chem Pharm,1976,24(3):549-551.
[4]Aoyama K,Tanaka N,Suzuki N,et al.Chemical and chemotaxonomic studies on the genus Pteris and related genera(Pteridaceae).ⅩⅥ.New pterosin derivatives from Pteris wallichiana Agardh.and P.semipinnata L[J].Chem Pharm,1977,25(9):2461-2564.
[5]Murakami T;Iida H,Tanaka N,et al.Chemical and chemotaxonomic studies of ferns.ⅩⅩⅩⅢ.Chemical studies on the constituents of Pteris longipes Don[J].Chem Pharm,1981,29(3):657-662.
[6]Tanaka N,Murakami T,Saiki Y,et al.Chemical and chemotaxonomic studies on the of ferns.ⅩⅩⅩⅦ.Chemical studies on the constituents of costa rican ferns(2)[J].Chem Pharm,1981,29(12):3455-3463.
[7]李金华,梁念慈,莫立儿,等.半边旗5种成分体外细胞毒活性比较及构效关系分析[J].药学学报,1998,33(9):641-644.
[8]Tanaka N;Murakami T;Saiki Y,et al.Chemical and chemotaxonomic studies of ferns.ⅩⅩⅩⅣ.Chemical studies on the constituents of Pteris purpureorachis Copel[J].Chem Pharm,1981,29(3):663-666.
[9]Murakami T;Tanaka N,Komazawa Y;et al.Chemical and chemotaxonomic studies of fronds.XLI.Additional compounds from Pteris purpureorachis Copel[J].Chem Pharm,1983,31(5):1502-1504.
[10]Salatino M L F,Prado J.Flavonoid glycosides of Pteridaceae from Brazil[J].Bioch Syst,1998,26:761-769.
[11]Imperato F.A new flavone glycoside from the fern Pteris cretica[J].Cell Mol L,1994(11-12):1115-1116.
[12]Imperato F,Nazzaro R.Luteolin 7-O-sophoroside from the fern Pteris cretica[J].Phytochem,1996,41(1):337-338.
[13]秦波,朱大元.凤尾蕨科植物中倍半萜类成分的研究进展(Ⅰ)[J].化学研究,2004,15(2):72-76.
[14]Chen Y H,Chang F R,Lu M C,et al.New benzyl glucosides and cytotoxic pterosin sesquiterpenes from Pteris ensiformis Burm[J].Molecules,2008,13(2):255-266.
[15]Zhang Q,Xuan L J.Pterisemipol,a novel sesquiterpenoid from Pteris semipinnata L[J].Chin Chem L,2007,18(11):1386-1388.
[16]王萍兰,刘志杰,李顺举,等.几种蕨类植物内生真菌抑制病原菌的筛选[J].九江医学,2007,22(03):51-53.
[17]吕应年,蒋桂香,吴科锋,等.半边旗中黄酮成分的分离鉴定与抗氧化活性研究[J].化学世界,2007,48(4):205-208.
[18]江苏新医学院.中药大辞典[M](第二版).上海:上海科学技术出版社,1986:782-783
[19]陈焕镛.《海南植物志》[M]第一卷.北京:科学出版社,1964:73.
[20]张朝芳,章绍尧.《浙江植物志》[M].浙江科学技术出版社,1993:82-83.
[21]朱慧明,吴铁,崔燎,等.半边旗多糖对肺腺癌SPCA-1细胞的诱导凋亡作用[J].中国新药杂志,2003,2(12):1-3.
[22]朱慧明,吴铁,崔燎,等.半边旗多糖对人肺腺癌细胞株SPCA-1凋亡和端粒酶的影响[J].中国新药杂志,2003,2(11):6-8.
[23]龚先玲,陈志红,典灵辉,等.半边旗挥发油化学成分气相色谱-质谱计算机联用技术分析[J].时珍国医国药,2005,16(08):697-698.
[24]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞的DNA、RNA及蛋白质生物合成的抑制作用[J].广东医学院学报,2002,20(04):247-248.
[25]何承伟,梁念慈,莫丽儿,等.半边旗提取物6F抑制HL-60细胞蛋白激酶C活性(英文)[J].中国药理学与毒理学杂志,2003,17(02):81-86.
[26]何承伟,梁念慈,莫丽儿,等.半边旗提取物6F对HL-60细胞还原型谷胱甘肽(GSH)水平的影响[J].广东医学院学报,2002,20(05):333-334.
[27]李金华,梁念慈,莫丽儿,等.半边旗有效化合物对肺癌细胞DNA拓扑异构酶、 TPK及c-myc基因的影响[J].癌症,2000,19(8):763-767.
[28]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞c-Myc、Bcl-2及PCNA表达的抑制作用[J].广东医学院学报,2002,20(03):165-166.
[29]何承伟,梁念慈,莫丽儿,等.半边旗抗肿瘤有效成分6F对HL-60细胞周期的影响及体外增效作用[J].癌症,1998,17(3):191-193.
[30]林意玲,吴平,廖海兰,等.半边旗二萜类化合物5F诱导人冀状胬肉成纤维细胞凋亡及对caspase-3表达的研究[J].中国药学杂志,2006,41(13):993-997.
[31]肖佐环,吴铁,吴志华,等.半边旗5F对系统性硬皮病患者成纤维细胞增殖和胶原合成的影响[J].中华皮肤科杂志,2003,36(01):31-34.
[32]何太平,莫丽儿,梁念慈.半边旗提取物5F对高转移卵巢癌细胞HO-8910PM侵袭转移的影响[J].中国药理学通报,2005,(05):540-544.
[33]何太平,莫丽儿,梁念慈.半边旗提取物5F对人高转移卵巢癌细胞HO-8910PM ETS-1mRNA和VEGF蛋白表达的影响[J].中药材,2005,28(4):307-309.
[34]何太平,莫丽儿,梁念慈.半边旗提取物5F对HO-8910PM细胞中NF-κB和FAK蛋白表达的影响[J].肿瘤防治杂志,2005,12(08):565-568.
[35]王京滨,梁念慈,莫丽儿.半边旗中二萜类化合物5F对K562细胞几种癌基因表达的影响[J].中国药理学通报,2002,8(04):418-421.
[36]刘义,吴育廉,邓亦峰,等.半边旗提取物5F对猪脑微管蛋白聚合的影响[J].中国药理学通报,2005,21(4):447-449.
[37]戴滨,崔燎,吴铁,等.半边旗提取物5F对SPCA-1细胞周期及DNA、RNA合成的影响[J].中国临床药理学与治疗学,2006,11(04):402-405.
[38]杨寿,吴平,何惠娟,等.半边旗二萜类化合物5F体外抗支气管哮喘小鼠气道纤维化的作用[J].中国医院药学杂志,2006,26(07):786-788.
[39]刘文,覃燕梅,梁念慈.半边旗中二萜类化合物5F对凝血酶诱导兔血小板聚集的影响[J].广东医学院学报,2000,18(01):9-10.
[40]何振辉,何太平,莫丽尔,等.白藜芦醇与半边旗二萜类化合物5F对活体血管生成的影响[J].实用医技杂志,2006,13(1):1-3.
[41]刘义,张薇,徐珠锦,等.半边旗提取物5F体外抑菌实验[J].牡丹江医学院学报, 2008,29(4):46-47.
[42]Tanaka N,Satake T,Takahashi A,et al.Chemical and chemotaxonomical studies of ferns.ⅩⅩⅪⅩ.chemical studies on the constituents of Pteris bella Tagawa and Pteridium aquilinum susp.wightianum(wall) shich[J].Chem Pharm,1982,30(10):3640-3646.
[43]Kuroyanagi M,Fukuoka M,Yoshihira K,et al.Circular dichroism and conformations of pterosins,1-indanone derivatives from braken[J].Chem Pharm,1979,27(3):731-741.
[44]Murakarni T,Maehashi H,Tanaka N,et al.Chemical and chemotaxonomical studies on filices.LV.Studies on the constituents of several species of Pteris[J].Yakugaku Zasshi,1985,105(7):640-648.
[45]Tori K,Seo S,Yoshimura Y,et al.Carbon-13 NMR spectra of saikosaponins A,C,D and F isolated from bupleurum falcatum L[J].Tetrahedr L,1976,17(46):4167-4170.
[46]Herz W,Sharma R P.New hydroxylated ent-kauranoic acids from Eupatorium album[J].J Org Chem,1976,41(6):1021-1026.
[47]Yamasaki K,Kohda H,Kobayyashi T,et al.Application of ~(13)C nuclear magnetic resonance spectroscopy to chemistry of glycosides:Structures of paniculosides-Ⅰ,-Ⅱ,-Ⅲ,-Ⅳ and Ⅴ diterpene glucosides of Stevia paniculata Lag[J].Chem Pharm,1977,25(11):2895-2899.
[48]张雪梅,李磊,张刚磊,等.3,4-二羟基苯甲醛合成工艺的改进[J].徐州师范大学学报(自然科学版),2006,24(3):52-54.
[49]邹国安.连翘和毛喉鞘蕊花活性成分及其质量分析研究[D].武汉:湖北中医学院,2006.
[50]Rahman M M A,Dewick P M,Jackson D E,et al.Lignans of Forsythia intermedia[J].Phytochem,1990,29(6):1971-1980.
[1]江苏新医学院编.中药大辞典[M](第二版).上海:上海科学技术出版,1986:216-217.
[2]Adolf W,Hecker E.On the active principles of the spurge familyⅢ.~* Skin irritant and cocarcinogenic factors from the caper spurge[J].Z Krebsforsch,1975,84(3):325-344.
[3]Appendino G,Porta C D,Conseil G,et al.A new P-glycoprotein inhibitor from the caper spurge(Euphorbia lathyris)[J].J Nat Prod.2003,66(1):140-142.
[4]徐珊,徐昌芬.肿瘤多药耐药性发生机制及中药逆转作用的研究进展[J].中国肿瘤生物治疗杂志,2006,13(6):404-411.
[5]危文亮,金梦阳,马冲,等.续随子油脂肪酸组成分析[J].中国油脂,2007,32(5):70-71.
[6]李昌珠,蒋丽娟,程树棋.生物柴油-绿色能源[M].北京:化学工业出版社,2004.
[7]Itolawa H,Ichihara Y,Yahagi M,et al.Lathyrane diterpenes from Euphorbia lathyris[J].Phytochem,1990,29(6):2025-2026.
[8]Liao S G,Zhan Z J,Yang S P,et al.Lathyranoic acid A:First secolathyrane diterpenoid in nature from Euphorbia lathyris[J].Org Lett,2005,7(7):1379-1382.
[9]Gao S,Liu H Y,Wang Y H,et al.Lathyranone A:A diterpenoid possessing an unprecedented skeleton from Euphorbia lathyris[J].Org Lett,2007,9(17):3453-3455.
[10]孔彩霞.千金子甲醇提取物抗肿瘤作用的实验研究及其有效成分理化性质的初步探讨[D].武汉:华中科技大学,2002.
[11]Itokawa H,Ichihara Y,Watanabe K,et al.An anti-tumor principle from Euphorbia lathyris[J].Planta Med.1989,55(3):271-272.
[12]黄晓桃,黄光英,薛存宽,等.千金子甲醇提取物抗肿瘤作用的实验研究[J].肿瘤防治研究,2004,31(9):556-557.
[13]李群,王琦,黄春凌,等.千金子炮制品中脂肪油成分的研究[J].中成药,1994,16(4):24-25.
[14]Masamoto Y,Ando H,Murata Y,et al.Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L[J].Bios Biot B,2003,7(3):631-634.
[15]Takara K,Sakaeda T,Okumura K.An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy[J].Curr Pharm Des,2006,12(3):273-286.
[16]Beck W T.The cell biology of multiple drug resistance[J].Bioch Pharma,1987,36(18):2879-2887.
[17]包鸿廷,韩曙光.一种治疗白血病的中药.中国:93103708.5[P].1994-10-5.
[18]邹义达.一种治疗膀胱癌的中药.中国:01131500.8[P].2002-4-17.
[19]王娟,陈金海山.一种治疗银屑病的中药组合物.中国:200410042859.5[P].2005-12-7.
[20]Appendino G,Porta C D,Conseil G,et al.An expeditious procedure for the isolation of ingenol from the seeds of Euphorbia lathyris[J].J Nat Prod,1999,62(1):76-79.
[21]National Institute of Advanced Industrial Science and Technology(AIST),Japan.Spectral Database for Organic Compounds SDBS[DB/OL].[2008-01-20]http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/direct_frame_top.cgi.
[22]杨雁芳,阎玉凝.中药枸骨叶的化学成分研究[J].中国中医药信息杂志,2002,9(4):33-34.
[23]Kupchan S M;Uchida I;Branfman A R;et al.Antileukemic principles isolated from Euphorbiaceae plants[J].Science,1976,191(4227):571-572.
[24]Fujiwara M;Ijichin K;Tokuhisa,K.;et al.Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate[J].Antim Ag Ch,1996,40(1):271-273.